235 related articles for article (PubMed ID: 17579511)
1. Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate.
Riley S; Wu JT; Leung GM
PLoS Med; 2007 Jun; 4(6):e218. PubMed ID: 17579511
[TBL] [Abstract][Full Text] [Related]
2. Influenza pandemic vaccines: spread them thin?
Fraser C
PLoS Med; 2007 Jun; 4(6):e228. PubMed ID: 17579513
[TBL] [Abstract][Full Text] [Related]
3. [Pandemic and prepandemic H5N1 influenza vaccines: a 2009 update].
Loulergue P; Launay O
Med Sci (Paris); 2009; 25(8-9):719-25. PubMed ID: 19765386
[TBL] [Abstract][Full Text] [Related]
4. Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.
Singh N; Pandey A; Mittal SK
Expert Rev Mol Med; 2010 Apr; 12():e14. PubMed ID: 20426889
[TBL] [Abstract][Full Text] [Related]
5. Confronting the avian influenza threat: vaccine development for a potential pandemic.
Stephenson I; Nicholson KG; Wood JM; Zambon MC; Katz JM
Lancet Infect Dis; 2004 Aug; 4(8):499-509. PubMed ID: 15288823
[TBL] [Abstract][Full Text] [Related]
6. Reducing the impact of the next influenza pandemic using household-based public health interventions.
Wu JT; Riley S; Fraser C; Leung GM
PLoS Med; 2006 Sep; 3(9):e361. PubMed ID: 16881729
[TBL] [Abstract][Full Text] [Related]
7. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
8. Changes in and shortcomings of control strategies, drug stockpiles, and vaccine development during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans.
Mei L; Song P; Tang Q; Shan K; Tobe RG; Selotlegeng L; Ali AH; Cheng Y; Xu L
Biosci Trends; 2013 Apr; 7(2):64-76. PubMed ID: 23612075
[TBL] [Abstract][Full Text] [Related]
9. Current status and future needs in diagnostics and vaccines for high pathogenicity avian influenza.
Swayne DE; Spackman E
Dev Biol (Basel); 2013; 135():79-94. PubMed ID: 23689886
[TBL] [Abstract][Full Text] [Related]
10. Development of live attenuated influenza vaccines against pandemic influenza strains.
Coelingh KL; Luke CJ; Jin H; Talaat KR
Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for seasonal and pandemic influenza.
Nichol KL; Treanor JJ
J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
[TBL] [Abstract][Full Text] [Related]
12. A simple mathematical approach to deciding the dosage of vaccine against pandemic H1N1 influenza.
Nishiura H; Iwata K
Euro Surveill; 2009 Nov; 14(45):. PubMed ID: 19941790
[TBL] [Abstract][Full Text] [Related]
13. One versus two doses: What is the best use of vaccine in an influenza pandemic?
Matrajt L; Britton T; Halloran ME; Longini IM
Epidemics; 2015 Dec; 13():17-27. PubMed ID: 26616038
[TBL] [Abstract][Full Text] [Related]
14. Strategies for broad global access to pandemic influenza vaccines.
Edwards KM; Sabow A; Pasternak A; Boslego JW
Curr Top Microbiol Immunol; 2009; 333():471-93. PubMed ID: 19768420
[TBL] [Abstract][Full Text] [Related]
15. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
[TBL] [Abstract][Full Text] [Related]
16. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands.
Nuño M; Chowell G; Gumel AB
J R Soc Interface; 2007 Jun; 4(14):505-21. PubMed ID: 17251132
[TBL] [Abstract][Full Text] [Related]
17. Current status and progress of prepandemic and pandemic influenza vaccine development.
Leroux-Roels I; Leroux-Roels G
Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
[TBL] [Abstract][Full Text] [Related]
18. Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.
Hasegawa H; Ichinohe T; Tamura S; Kurata T
Expert Rev Vaccines; 2007 Apr; 6(2):193-201. PubMed ID: 17408369
[TBL] [Abstract][Full Text] [Related]
19. The pandemic threat: are we prepared?
Lewis KK
Issue Brief (Mass Health Policy Forum); 2006 Jun; (29):1-14. PubMed ID: 16886304
[TBL] [Abstract][Full Text] [Related]
20. Optimal control of vaccination dynamics during an influenza epidemic.
Jaberi-Douraki M; Moghadas SM
Math Biosci Eng; 2014 Oct; 11(5):1045-63. PubMed ID: 25347806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
